Under construction – not a live service
Sign in
Not yet taking people in GuadeloupeNo phase

Compares how brain ischemia progresses in Afro-Caribbean and Nantes stroke patients

Observes how brain ischemia progresses in Afro-Caribbean adults compared with patients from Nantes.

Plain-language title generated from the registry record
Registry title: Study of the Rate of Progression of Cerebral Ischemia in Afro-Caribbeans

Key facts

Where
Pointe-à-Pitre, GuadeloupeSee the site

Where in Guadeloupe

  • Centre Hospitalier Universitaire de la GuadeloupePointe-à-Pitre, GuadeloupeNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Centre Hospitalier Universitaire de la Guadeloupe
Trial code
NCT07230925
Record updated
17 November 2025
Original description
To compare the progression of cerebral ischemia from HF in Afro-Caribbean patients admitted to the CHUG to that of patients from Nantes included in the national ETIS registry.Read full original descriptionShow less

Study of the Rate of Progression of Cerebral Ischemia in Afro-Caribbeans

To compare the progression of cerebral ischemia from HF in Afro-Caribbean patients admitted to the CHUG to that of patients from Nantes included in the national ETIS registry.

inclusion criteria:; Patients aged 18 and over, admitted for IC due to LVO verified by medical imaging and hospitalized in neurology; Patients residing in Guadeloupe; Afro-Caribbean patients: of African ancestry; Emergency inclusion, with exemption from obtaining consent due to the immediate life-threatening emergency situation of the patient (Article L1122-1-3 of the French Public Health Code); as soon as possible, consent to continue will be sought from the patient or, if applicable, from a relative or a trusted person; Patients affiliated to a social security scheme or equivalent; exclusion criteria:; Patients under 18 years old; Non-resident patients in Guadeloupe; Protected persons (articles L1121-5, L1121-6 and L121-8 of the Public Health Code): pregnant or breastfeeding women, persons deprived of their liberty, under guardianship or curatorship); Withdrawal of consent during the study; Patients not affiliated to a social security or equivalent scheme.

ClinicalTrials.gov NCT07230925